Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q52573049)
Watch
English
Vascular disrupting agents.
scientific article published in November 2006
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16927308
retrieved
3 May 2018
reference URL
http://europepmc.org/abstract/MED/16927308
title
Vascular disrupting agents.
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16927308
retrieved
3 May 2018
reference URL
http://europepmc.org/abstract/MED/16927308
author name string
Pilat MJ
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16927308
retrieved
3 May 2018
reference URL
http://europepmc.org/abstract/MED/16927308
Lorusso PM
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16927308
retrieved
3 May 2018
reference URL
http://europepmc.org/abstract/MED/16927308
publication date
1 November 2006
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16927308
retrieved
3 May 2018
reference URL
http://europepmc.org/abstract/MED/16927308
published in
Journal of Cellular Biochemistry
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16927308
retrieved
3 May 2018
reference URL
http://europepmc.org/abstract/MED/16927308
volume
99
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16927308
retrieved
3 May 2018
reference URL
http://europepmc.org/abstract/MED/16927308
issue
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16927308
retrieved
3 May 2018
reference URL
http://europepmc.org/abstract/MED/16927308
page(s)
1021-1039
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16927308
retrieved
3 May 2018
reference URL
http://europepmc.org/abstract/MED/16927308
cites work
Antitumor activity of TZT-1027, a novel dolastatin 10 derivative.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FJCB.20783
retrieved
21 January 2018
Enhancement of the anti-tumour effects of the antivascular agent 5,6-dimethylxanthenone-4-acetic acid (DMXAA) by combination with 5-hydroxytryptamine and bioreductive drugs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FJCB.20783
retrieved
21 January 2018
Production of tumour necrosis factor-alpha by cultured human peripheral blood leucocytes in response to the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid (NSC 640488).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FJCB.20783
retrieved
21 January 2018
Identifiers
DOI
10.1002/JCB.20783
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16927308
retrieved
3 May 2018
reference URL
http://europepmc.org/abstract/MED/16927308
PubMed publication ID
16927308
1 reference
stated in
Europe PubMed Central
PubMed publication ID
16927308
retrieved
3 May 2018
reference URL
http://europepmc.org/abstract/MED/16927308
ResearchGate publication ID
6861594
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit